2024

• Campbell, A., Trotman, J., Lane, S., Dickinson, M., Quach, H., Enjeti, A., Ku, M., Gregory, G., Hapgood, G., Ho, P., Greenwood, M., Mulligan, S., et al (2024). Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal Medicine Journal, 54(2), 328-336. [More Information]
• Kim, N., McErlean, G., Yu, S., Kerridge, I., Greenwood, M., Lourenco, R. (2024). Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review. Transplantation and Cellular Therapy, 30(5), 542.e1-542.e29. [More Information]
• Issa, G., McMahon, C., Traer, E., Zwaan, C., Grove, C., Stone, R., Shami, P., Mantzaris, I., Greenwood, M., Shukla, N., et al (2024). Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101). Journal of Clinical Oncology, , JCO.24.00826. [More Information]

2023

• Mills, G., Di Ciaccio, P., Tang, C., Chadwick, V., Mason, K., Campbell, B., Shipton, M., Shanavas, M., Morris, K., Greenwood, M., Langfield, J., et al (2023). Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study. Leukemia & Lymphoma, 64(2), 319-328. [More Information]
• Dyer, G., Gottlieb, D., Hertzberg, M., Brown, L., Hogg, M., Huang, G., Ward, C., Kerridge, I., Tapp, C., Brice, L., Greenwood, M., et al (2023). Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey. Clinical Nursing Research, 32(8), 1134-1144. [More Information]
• McEwan, A., Kerridge, I., Greenwood, M., Ward, C., Ritchie, D., Szer, J., Gardiner, E., Colic, A., Sipavicius, J., Panek-Hudson, Y. (2023). Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation. Internal Medicine Journal, 53(12), 2162-2174. [More Information]
• Moore, J., Hamad, N., Gottlieb, D., Bajel, A., Ritchie, D., Yeung, D., Greenwood, M., Purtill, D., Tran, S., Solterbeck, A., et al (2023). Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study. Blood Advances, 7(18), 5554-5565. [More Information]
• Lindsay, J., Leisenring, W., Greenwood, M., Chen, S., Kong, D., Slavin, M., Boeckh, M., Fredricks, D., Liu, C., Pergam, S., et al (2023). Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms. Blood Advances, 7(13), 3140-3145. [More Information]
• Blennerhassett, R., Othman, J., Biscoe, A., Kliman, D., Mills, G., Blyth, E., Micklethwaite, K., Kwan, J., Bilmon, I., Bhattacharyya, A., Stevenson, W., Greenwood, M., Gottlieb, D., Kerridge, I., et al (2023). Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis. Internal Medicine Journal. [More Information]
• McErlean, G., Tapp, C., Brice, L., Gilroy, N., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Hertzberg, M., Ward, C., Kerridge, I., et al (2023). Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey. BMC Psychology, 11(1). [More Information]
• Thomson, A., Rehn, J., Heatley, S., Eadie, L., Page, E., Schutz, C., McClure, B., Sutton, R., Dalla-Pozza, L., Moore, A., Greenwood, M., et al (2023). Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients. Cancers, 15(19). [More Information]
• Di Ciaccio, P., Mills, G., Shipton, M., Campbell, B., Gregory, G., Langfield, J., Greenwood, M., McKeague, S., Shanavas, M., Eslick, R., Bilmon, I., et al (2023). The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance. British Journal of Haematology. [More Information]

2022

• McErlean, G., Brice, L., Gilroy, N., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Hertzberg, M., Brown, L., Ward, C., Kerridge, I., et al (2022). Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey. Journal of Cancer Survivorship, 16(2), 432-444. [More Information]
• Latham, S., Hughes, E., Budgen, B., Ross, D., Greenwood, M., Bradstock, K., Dalla-Pozza, L., Huang, L., Law, T., Doculara, L., et al (2022). Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR. Journal of molecular diagnostics, 24(6), 632-641. [More Information]
• Kliman, D., Tran, S., Kennedy, G., Curley, C., McLean, A., Gottlieb, D., Kwan, J., Ritchie, D., Chee, L., Spencer, A., et al (2022). The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR. Bone Marrow Transplantation, 57(6), 982-989. [More Information]
• Lindsay, J., Krantz, E., Morris, J., Sweet, A., Tverdek, F., Joshi, A., Yeh, R., Hill, J., Greenwood, M., Chen, S., et al (2022). Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center. Transplantation and Cellular Therapy, 28(8), 511.e1-511.e10. [More Information]

2021

• Greenwood, M., Trahair, T., Sutton, R., Osborn, M., Kwan, J., Mapp, S., Howman, R., Anazodo, A., Wylie, B., D’Rozario, J., Bradstock, K., et al (2021). An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL. Blood Advances, 5(24), 5574-5583. [More Information]
• Hamad, N., Ananda-Rajah, M., Gilroy, N., MacIntyre, R., Gottlieb, D., Ritchie, D., Harrison, S., Kennedy, G., Watson, A., Greenwood, M., Shaw, P., et al (2021). Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement. Internal Medicine Journal, 51(8), 1321-1323. [More Information]
• McCaughan, G., Di Ciaccio, P., Ananda-Rajah, M., Gilroy, N., MacIntyre, R., Teh, B., Weinkove, R., Curnow, J., Szer, J., Enjeti, A., Mulligan, S., Trotman, J., Ho, P., Greenwood, M., et al (2021). COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement. Internal Medicine Journal, 51(5), 763-768. [More Information]
• Lindsay, J., Othman, J., Kerridge, I., Fay, K., Stevenson, W., Arthur, C., Chen, S., Kong, D., Pergam, S., Liu, C., Greenwood, M., et al (2021). Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance. Transplant Infectious Disease, 23(3). [More Information]
• Lindsay, J., Othman, J., Yong, M., Ritchie, D., Chee, L., Tay, K., Tio, S., Kerridge, I., Fay, K., Stevenson, W., Greenwood, M., et al (2021). Dynamics of Epstein–Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant. Transplant Infectious Disease, 23(5), e13719. [More Information]
• Purtill, D., Hutchins, C., Kennedy, G., McClean, A., Fraser, C., Shaw, P., Chiappini, P., Tao, H., Ma, D., Kabani, K., Greenwood, M., Gottlieb, D., et al (2021). Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic. Transplantation and Cellular Therapy, 27(12), 1022.e1-1022.e6. [More Information]
• Lindsay, J., Kerridge, I., Wilcox, L., Tran, S., O'Brien, T., Greenwood, M., Chen, S., Kong, D., Pergam, S., Liu, C., et al (2021). Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report. Transplantation and Cellular Therapy, 27(9), 7.98E+03-7.98E+12. [More Information]
• Rutting, S., Badal, T., Wallis, R., Schoeffel, R., Roche, N., Cottee, A., Chapman, D., Greenwood, M., Farah, C., King, G., Thamrin, C. (2021). Long-term variability of oscillatory impedance in stable obstructive airways disease. European Respiratory Journal, 58(1), 43182020. [More Information]
• Gifford, G., Hesson, L., Wong, J., Carroll, A., Gabrielli, S., Bai, L., Xia, W., Stevenson, W., Greenwood, M. (2021). Poor mobilization of autologous CD34+ peripheral blood stem cells in haematology patients undergoing autologous stem cell transplantation is associated with the presence of variants in genes implicated in clonal haematopoiesis of indeterminant potential. British Journal of Haematology, 193(4), 841-844. [More Information]
• Brice, L., Gilroy, N., Dyer, G., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Hertzberg, M., Brown, L., Ward, C., Kerridge, I., et al (2021). Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors. Journal of Psychosocial Oncology, 39(4), 534-552. [More Information]
• Lindsay, J., Othman, J., Kong, Y., Yip, A., van Hal, S., Larsen, S., Bryant, C., Gibson, J., Kerridge, I., Fay, K., Stevenson, W., Chen, S., Greenwood, M., et al (2021). SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases, 8(11). [More Information]

2020

• Biennerhassett, R., Kwan, J., Coyle, L., Wong, K., Greenwood, M. (2020). Adult B- and T-lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes—a short report from two Sydney centres. British Journal of Haematology, 191(2), e58-e60. [More Information]
• Lwin, Y., Kennedy, G., Gottlieb, D., Kwan, J., Ritchie, D., Szer, J., Milliken, S., Browett, P., Spencer, A., Butler, A., Greenwood, M., et al (2020). Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation, 26(12), 2252-2261. [More Information]
• Hamad, N., Gottlieb, D., Ritchie, D., Kennedy, G., Watson, A., Greenwood, M., Doocey, R., Perera, T., Spencer, A., Wong, E., Shaw, P., et al (2020). Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement. Internal Medicine Journal, 50(6), 774-775. [More Information]
• Lindsay, J., Yong, M., Greenwood, M., Kong, D., Chen, S., Rawlinson, W., Slavin, M. (2020). Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation. Reviews in Medical Virology, 30(4), e2108. [More Information]
• Brice, L., McErlean, G., Donovan, C., Tapp, C., Gilroy, N., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Ward, C., Kerridge, I., et al (2020). Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study. European Journal of Oncology Nursing, 49, 1-9. [More Information]
• Lwin, Y., Lindsay, J., Reid, C., Wong, K., Kerridge, I., Arthur, C., Fay, K., Stevenson, W., Greenwood, M. (2020). Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens. Bone Marrow Transplantation, 55, 1638-1641. [More Information]
• Arthur, C., Jeffrey, A., Yip, E., Katsioulas, V., Nalpantidis, A., Kerridge, I., Greenwood, M., Coyle, L., Mackinlay, N., Fay, K., Stevenson, W., et al (2020). Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. Leukemia & Lymphoma, 61(4), 831-839. [More Information]
• Othman, J., Greenwood, M., Moore, J., Larsen, S., Watson, A., Arthur, C., Bhattacharyya, A., Bilmon, I., Blyth, E., Bryant, A., Gibson, J., Kerridge, I., Stevenson, W., Gottlieb, D., et al (2020). Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG. Biology of Blood and Marrow Transplantation, 26(10), 1868-1875. [More Information]
• Purtill, D., Antonenas, V., Chiappini, P., Tong, D., O’Flaherty, E., Bajel, A., Kabani, K., Larsen, S., Tan, S., Hutchins, C., Greenwood, M., Gottlieb, D., et al (2020). Variable CD341 recovery of cryopreserved allogeneic HPC products: Transplant implications during the COVID-19 pandemic. Blood Advances, 4(17), 4147-4150. [More Information]

2019

• Dyer, G., Gilroy, N., Brice, L., Kabir, M., Gottlieb, D., Huang, G., Hogg, M., Brown, L., Greenwood, M., Larsen, S., Ward, C., Kerridge, I., et al (2019). A survey of infectious diseases and vaccination uptake in long-term Hematopoietic Stem Cell Transplant survivors in Australia. Transplant Infectious Disease, 21(2), 1-11. [More Information]

2018

• Dyer, G., Brice, L., Gilroy, N., Kabir, M., Hertzberg, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Huang, G., Ward, C., Kerridge, I., et al (2018). Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia. Bone Marrow Transplantation, 53(7), 926-931. [More Information]
• Gifford, G., Gabrielli, S., Gill, A., Greenwood, M., Wong, K., Best, G., Nevell, D., Mcilroy, K., Kliman, D., Ilmay-Gillespie, L., Stevenson, W., et al (2018). Lymphoma cell-of–origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts. British Journal of Haematology, 181(2), 272-275. [More Information]
• Dyer, G., Brice, L., Schifter, M., Gilroy, N., Kabir, M., Hertzberg, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Huang, G., Hogg, M., Ward, C., Kerridge, I., et al (2018). Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in Australia. Australian Dental Journal, 63(3), 312-319. [More Information]

2017

• Brice, L., Gilroy, N., Dyer, G., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Kwan, J., Hertzberg, M., Brown, L., Ward, C., Gottlieb, D., Kerridge, I., et al (2017). Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? Supportive Care in Cancer, 25(2), 421-427. [More Information]
• Smith, J., Poon, C., Gilroy, N., Kabir, M., Brice, L., Dyer, G., Hogg, M., Greenwood, M., Moore, J., Hertzberg, M., Ward, C., Kerridge, I., et al (2017). Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia. Supportive Care in Cancer, 25(1), 137-144. [More Information]
• Lindsay, J., Sandaradura, I., Wong, K., Arthur, C., Stevenson, W., Kerridge, I., Fay, K., Coyle, L., Greenwood, M. (2017). Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation. Journal of Antimicrobial Chemotherapy, 72(12), 3414-3419. [More Information]

2016

• Dyer, G., Gilroy, N., Bradford, J., Brice, L., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Hertzberg, M., Kwan, J., Ward, C., Kerridge, I., et al (2016). A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. British Journal of Haematology, 172(4), 592-601. [More Information]
• Dyer, G., Larsen, S., Gilroy, N., Brice, L., Greenwood, M., Hertzberg, M., Kabir, M., Brown, L., Hogg, M., Huang, G., Gottlieb, D., Ward, C., Kerridge, I., et al (2016). Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT). Cancer Medicine, 5(7), 1702-1716. [More Information]
• Lindsay, J., Kabir, M., Gilroy, N., Dyer, G., Brice, L., Moore, J., Greenwood, M., Hertzberg, M., Gottlieb, D., Larsen, S., Ward, C., Kerridge, I., et al (2016). Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia. Cancer Medicine, 5(12), 3606-3614. [More Information]
• Gifford, G., Gilroy, N., Dyer, G., Brice, L., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Gottlieb, D., Hertzberg, M., Ward, C., Kerridge, I., et al (2016). The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Bone Marrow Transplantation, 51(10), 1361-1368. [More Information]
• Dyer, G., Gilroy, N., Brown, L., Hogg, M., Brice, L., Kabir, M., Greenwood, M., Larsen, S., Moore, J., Hertzberg, M., Ward, C., Kerridge, I., et al (2016). What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia. Biology of Blood and Marrow Transplantation, 22(4), 731-743. [More Information]

2014

• Xia, W., Ma, C., Reid, C., Bai, L., Wong, K., Kerridge, I., Ward, C., Greenwood, M. (2014). Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation. Journal of Clinical Apheresis, 29(6), 322-330. [More Information]